Gene Query: SEMA4C

Dataset Description Geneva Score
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 59.91
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 46.77
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 44.7
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 42.59
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 41.47
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 40.87
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 40.87
Transcriptome analysis of kidney organoids 40.86
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 36.25
Genome wide expression change in LCC2 and MCF-7 cells 35.52
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 34.55
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 33.98
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 32.02
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 31.93
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 29.54
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 28.34
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 28.34
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 28.25
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 27.82
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 27.82
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 25.63
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 24.81
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 24.43
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 23.41
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 22.66
RNA-Seq analysis of breast cancer cells after shikonin treatment 21.9
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 21.57
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 21.28
Role of COP1 on MAP kinase transcriptional output in melanoma 19.35
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 19.24
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 19.24
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 19.24
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 18.98
Differential analysis of gene regulation at transcript resolution by RNA-Seq 18.98
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 18.78
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 18.0
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 17.85
mRNA recovered upon RNF219 IP. [RNA-IP] 17.64
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 17.56
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 17.48
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 17.1
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 16.75
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 16.36
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 16.14
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 16.14
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 16.11
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 16.11
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 16.01
Ro60-knockout cells 15.75
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 15.54
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 15.54
Controlling for gene expression changes in transcription factor protein networks. 15.23
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 14.95
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 14.95
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 14.91
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 14.77
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 14.47
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 14.47
RNA-seq of shEZH2 cells 14.32
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 14.1
Differential gene expression in Jagged1 treated human dental pulp cells. 13.91
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 13.8
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 13.38
DJ-1 is dispensable for human stem cell homeostasis 13.38
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 13.38
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 13.3
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 13.17
RNA-seq of resting and activated CD4+ T cells +-JQ1 13.17
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 13.02
Silencing p300 in MCF7 cells to study expression and alternative splicing 12.79
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 12.64
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 12.35
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 12.27
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 12.16
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 12.03
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 12.03
CD73 knockdown effect in pancreatic cancer cell lines 11.56
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 11.55
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 11.5
Patient-derived luminal breast cancer xenografts with progestins 11.5
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 11.5
Gene expression changes upon drug withdrawal (Mel888 cell line) 11.45
Impact on erythroid progenitor type on erythroid differntiation 11.42
High level DNA repair gene expression in human ES cells 11.37
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 11.22
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 11.14
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 11.04
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 10.89
snRNAs as regulators of alternative splicing 10.71
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 10.7
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 10.67
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 10.54
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 10.53
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 10.53
Differential Gene Expression between MCF10A and MCF7 cells 10.36
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 10.24
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 10.22
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 10.2
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 10.16
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 10.14
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 10.14
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 10.13
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 10.13
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 10.04
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 10.03
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 10.03
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 9.86
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.74
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 9.63
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 9.62
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 9.55
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.47
Differential Protein Occupancy Profiling of the mRNA Transcriptome 9.44
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 9.43
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 9.39
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 9.38
In situ CAPTURE of chromatin interactions by biotinylated dCas9 9.38
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 9.17
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 9.1
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 9.09
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 9.07
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 9.07
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 9.02
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 9.01
RNA-seq analysis of differentiating human erythroblasts 8.96
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 8.94
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 8.94
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 8.93
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 8.93
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 8.83
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 8.81
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 8.8
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 8.79
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 8.79
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 8.67
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 8.64
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 8.63
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 8.62
Functional role of SLIT2 and ROBO1 in trophoblasts 8.62
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 8.62
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 8.59
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 8.58
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.58
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 8.57
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 8.51
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 8.43
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 8.41
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 8.41
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 8.38
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 8.38
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 8.35
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 8.33
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 8.31
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 8.29
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.2
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 8.15
The pause-initiation limit restricts transcription activation in human cells 8.13
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 8.13
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 8.1
Transcriptome sequencing of K-562 cells 8.06
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 8.05
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 8.04
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 7.99
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 7.98
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 7.92
LncRNA-GAS5 negative regulation of YAP-target genes expression 7.91
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 7.85
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 7.83
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 7.81
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 7.78
Overexpression and knockdown experiment for circCSNK1G3 7.76
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 7.67
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.67
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.67
PTHrP overexpression in MCF7 cells 7.65
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 7.63
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 7.62
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 7.56
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 7.51
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 7.51
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 7.51
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 7.43
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 7.42
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 7.42
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 7.41
SRSF2 mutations impair hematopoiesis and alter exon recognition 7.41
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 7.38
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 7.36
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 7.35
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 7.33
Genome-wide chromatin analysis of Ewing sarcoma 7.33
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 7.33
RNA-Seq with and without RNase treatment in PCa cell lines 7.3
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 7.22
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 7.21
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 7.18
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 7.14
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 7.02
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 6.99
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 6.98
Gene expression changes after LOC550643 silencing 6.93
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 6.92
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 6.92
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.81
High-throughput sequencing of pluripotent cells 6.8
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 6.74
IL-33 activates tumor stroma to promote intestinal polyposis 6.72
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.71
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.71
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 6.63
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 6.63
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 6.6
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 6.59
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 6.56
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 6.53
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 6.51
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 6.49
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 6.48
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 6.46
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 6.43
Epigenomic landscape during organ formation in human early embryos 6.42
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 6.35
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 6.34
Expression profiling of MCF-7 cells with treatment of TCDD 6.34
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 6.29
Gene expression profile in breast cancer cell lines using RNA sequencing 6.27
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 6.26
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 6.19
Gene expression regulated by CSA and CSB in neuroblastoma cell line 6.18
MCF-7 as a model for functional analysis of breast cancer risk variants 6.17
Differentially expressed vascular development genes for iPSC-ECs from CDI 6.12
The cohesin complex prevents Myc-induced replication stress 6.11
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 6.08
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.08
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 6.05
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 6.04
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 6.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 6.02
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 6.0
Ectoderm specification of H1 human embryonic stem cells 6.0
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 6.0
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 5.98
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 5.94
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 5.92
Functional role of CPPED1 in trophoblasts. 5.79
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 5.79
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.79
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.79
circRNA-sequencing 5.78
CD86 regulates a pro-survival signal in myeloma cells 5.75
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.75
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.75
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 5.75
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 5.74
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 5.74
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 5.73
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.72
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 5.71
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.71
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 5.7
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 5.64
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 5.64
The effect of Abl kinases on non-small cell carcinoma global transcriptome 5.61
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 5.59
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.58
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.58
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.58
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.58
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.57
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 5.57
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.55
Mechanistic Model-Guided Study of Embryonic Morphogenesis 5.45
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 5.45
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 5.43
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 5.41
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.37
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 5.36
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.31
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.31
The human blood-nerve barrier transcriptome 5.31
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 5.31
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 5.29
Hepatitis C virus functionally sequesters miR-122 5.29
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 5.28
LIN28A modulates splicing and gene expression programs in breast cancer cells 5.24
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 5.24
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 5.09
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 5.08
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 5.07
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 5.07
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 5.07
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 5.0
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 5.0
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.99
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.99
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 4.93
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 4.91
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 4.88
Redifferentiation of expanded human islet β cells by inhibition of ARX 4.85
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 4.83
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 4.83
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 4.82
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.82
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 4.77
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 4.77
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 4.76
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 4.76
Studying the selectivity of a small molecule Synucleozid on transcriptome 4.75
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.68
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.66
CDK4/6 inhibitor resistance in prostate cancer 4.62
Epigenome regulation during epidermal lineage commitment 4.6
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.57
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 4.57
Transcriptome analysis of SKI knock-out in HL60 cells 4.57
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.55
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.53
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.53
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.44
An acquired vulnerability of drug resistant melanoma with therapeutic potential 4.42
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 4.42
Genome-wide discovery of human splicing branchpoints [RNAse] 4.42
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 4.4
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.39
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 4.38
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 4.33
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 4.32
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 4.26
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 4.24
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.24
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 4.23
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.22
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 4.2
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.17
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.14
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 4.14
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 4.14
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 4.09
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 4.0
iPSC-Derived Cholangiocytes 3.92
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.89
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.86
Epigenome regulation during epidermal lineage commitment [RNA-seq] 3.83
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.79
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 3.78
Investigate A2M treatment on human prostate cancer and mouse liver 3.69
Investigate A2M treatment on human prostate cancer xenograft in mice 3.69
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.69
X-Ray induced DNA-Hydroxymethylation changes 3.67
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 3.65
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.6
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.6
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 3.57
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.5
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.5
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 3.44
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 3.42
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 3.4
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.38
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.33
Deep RNA sequencing of the human placental transcriptome 3.28
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.26
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 3.22
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 3.22
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.2
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.19
quanTIseq: quantifying immune contexture of human tumors 3.18
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 3.16
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 3.16
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.15
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.14
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 3.12
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.12
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.11
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.1
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.06
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.97
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 2.9
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.89
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.86
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 2.81
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.77
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.77
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.76
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 2.73
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.66
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.65
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.62
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.62
Bone marrow derived human B cells [normal proB] 2.61
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 2.59
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 2.59
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.56
BASP1 modifies the Tamoxifen response 2.52
Genome-wide discovery of human splicing branchpoints 2.48
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 2.47
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 2.47
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.42
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.4
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.4
RNA-seq analysis of control and Myc-induced U2OS cells 2.33
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.32
Glucose inhibits cardiac maturation through nucleotide biosynthesis 2.28
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 2.27
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 2.19
Gene expression profile of human placenta from T. Cruzi infected mothers 2.19
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.18
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.1
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.07
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 2.05
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 2.03
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 1.96
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.94
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.86
Gene expression profile difference among renal location in a stone former 1.85
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.84
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.81
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.76
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.76
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.76
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.64
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.64
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.61
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.6
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.59
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.56
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.56
RNA-seq analysis of breast cancer 1.48
RNA-seq analysis and shRNA screen of breast cancer 1.48
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.48
The DNA methylation landscape of human melanoma 1.41
The DNA methylation landscape of human melanoma [RNA-Seq] 1.41
Gene expression profile of CRC-derived HILEC 1.39
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.37
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.34
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.26
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 1.25
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 1.25
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.23
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 1.19
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 1.19
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.17
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.15
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.09
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.09
RNA-seq differential expression studies: more sequence, or more replication? 1.08
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 1.07
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.07
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.06
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.04
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.99
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.88
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.88
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.88
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.88
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 0.87
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.78
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.75
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.7
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.62
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.59
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.59
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.58
Fusion discovery in breast cancer cell line 0.58
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.55
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 0.55
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.53
Gene expression analysis of breast cancer cell-lines 0.52
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.52
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.5
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.5
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.5
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.42
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.42
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.41
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.39
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 0.38
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.37
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.34
Global gene expression profile of dasatinib-resistant RCH-ACV cells 0.33
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.32
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.3
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.29
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.27
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.25
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.22
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.22
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.21
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.19
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.14
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.12
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.11
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.07
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.06
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 0.06
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.04
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.0
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.0
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation